HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hubert Vaudry Selected Research

5-HT4 Serotonin Receptors

12/2005Expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas.
5/2005Abnormal sensitivity of cortisol-producing adrenocortical adenomas to serotonin: in vivo and in vitro studies.
1/2003Overexpression of serotonin4 receptors in cisapride-responsive adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia causing Cushing's syndrome.
3/2002Characterization of serotonin(4) receptors in adrenocortical aldosterone-producing adenomas: in vivo and in vitro studies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hubert Vaudry Research Topics

Disease

17Neoplasms (Cancer)
01/2020 - 03/2002
11Neurodegenerative Diseases (Neurodegenerative Disease)
01/2020 - 06/2008
10Pheochromocytoma
09/2010 - 01/2003
5Cushing Syndrome
10/2015 - 01/2003
5Tetraploidy
12/2014 - 11/2010
5Inflammation (Inflammations)
05/2012 - 07/2004
5Hyperplasia
11/2006 - 01/2003
4Stroke (Strokes)
06/2011 - 10/2007
4Ischemia
06/2011 - 04/2008
4Adenoma (Adenomas)
04/2006 - 03/2002
3Bradycardia
05/2016 - 11/2005
3Body Weight (Weight, Body)
09/2010 - 01/2005
3Neoplasm Metastasis (Metastasis)
07/2009 - 01/2009
3Acth-Independent Macronodular Adrenal Hyperplasia
11/2006 - 01/2003
2Parkinson Disease (Parkinson's Disease)
01/2018 - 01/2016
2Neuroblastoma
01/2016 - 01/2008
2Starvation
07/2014 - 10/2007
2Hypogonadism (Hypergonadotropic Hypogonadism)
06/2014 - 06/2013
2Obesity
01/2012 - 05/2003
2Fetal Alcohol Spectrum Disorders
08/2009 - 04/2002
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
07/2007 - 03/2007
1Binge Drinking
11/2017
1Alcoholism (Alcohol Abuse)
06/2017
1Cerebellar Diseases (Cerebellar Syndrome)
06/2017
1Spasm (Spasms)
05/2016
1Complementation Group D Xeroderma Pigmentosum
10/2015
1Acromegaly
10/2015
1Ganglioneuroma
10/2015
1Brain Ischemia (Cerebral Ischemia)
11/2014
1Infections
09/2012
1Brain Injuries (Brain Injury)
05/2012
1Diabetes Mellitus
01/2012
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
06/2011
1Lymphoma (Lymphomas)
06/2011
1Infarction (Infarctions)
06/2011
1Mitochondrial Diseases (Mitochondrial Disease)
05/2011
1Cardiomyopathies (Cardiomyopathy)
01/2011

Drug/Important Bio-Agent (IBA)

20Peptides (Polypeptides)IBA
05/2016 - 11/2002
18Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
11/2017 - 04/2002
7NeuropeptidesIBA
06/2008 - 06/2003
5Adrenocorticotropic Hormone (ACTH)FDA Link
10/2015 - 01/2003
5Norepinephrine (Noradrenaline)FDA LinkGeneric
12/2014 - 06/2006
5CatecholaminesIBA
05/2012 - 06/2006
5Proteins (Proteins, Gene)FDA Link
05/2010 - 06/2003
5Hydrocortisone (Cortisol)FDA LinkGeneric
11/2006 - 01/2003
4Ethanol (Ethyl Alcohol)IBA
11/2017 - 04/2002
4KisspeptinsIBA
07/2009 - 01/2009
4Serotonin (5 Hydroxytryptamine)IBA
11/2006 - 03/2002
45-HT4 Serotonin ReceptorsIBA
12/2005 - 03/2002
3Antimicrobial Cationic PeptidesIBA
12/2014 - 01/2012
3Caspase 3 (Caspase-3)IBA
11/2014 - 05/2011
3CytokinesIBA
07/2014 - 07/2004
3Messenger RNA (mRNA)IBA
06/2011 - 08/2006
3Secretogranin IIIBA
08/2006 - 06/2003
3AldosteroneIBA
04/2006 - 03/2002
2Neuroprotective AgentsIBA
01/2018 - 10/2007
2EnzymesIBA
05/2016 - 12/2007
2CeruletideIBA
10/2015 - 01/2012
2Kisspeptin-1 ReceptorsIBA
06/2013 - 07/2009
2Reactive Oxygen Species (Oxygen Radicals)IBA
08/2011 - 05/2011
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2011 - 06/2008
2Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA
05/2011 - 11/2006
2CaspasesIBA
11/2008 - 10/2007
2urotensin IIIBA
05/2008 - 04/2008
2Glutamine (L-Glutamine)FDA Link
10/2007 - 07/2006
2Myelin-Oligodendrocyte GlycoproteinIBA
07/2007 - 03/2007
2Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
11/2006 - 05/2005
2Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA
11/2006 - 03/2005
2Gonadotropin-Releasing Hormone (GnRH)FDA Link
07/2005 - 05/2005
2Cisapride (Propulsid)FDA Link
01/2003 - 03/2002
15-methoxy-methylindoleacetic acid (DBI)IBA
01/2020
1AntioxidantsIBA
09/2019
1Dopamine (Intropin)FDA LinkGeneric
01/2018
1Pharmaceutical PreparationsIBA
06/2017
1Environmental Pollutants (Pollutants, Environmental)IBA
06/2017
1Bacillus subtilis sboA proteinIBA
05/2016
1Sulfides (Thioethers)IBA
05/2016
11-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA
01/2016
1Trinitrotoluene (TNT)IBA
11/2015
1Trefoil FactorsIBA
10/2015
1Corticotropin-Releasing HormoneIBA
10/2015
1Growth Hormone (Somatotropin)IBA
10/2015
1Phosphotransferases (Kinase)IBA
07/2014
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
07/2014
1Amino AcidsFDA Link
06/2014
1Glucagon-Like Peptide 1 (GLP 1)IBA
01/2012
1Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2012
1MagaininsIBA
01/2012
1AmidesIBA
01/2012
1Leucine (L-Leucine)FDA Link
01/2012
1LigandsIBA
01/2012
1peptide-Gly-Leu-amideIBA
01/2012
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
06/2011
1Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA
06/2011
1Interleukin-6 (Interleukin 6)IBA
06/2011
1Protein Kinase CIBA
05/2011
1Glutamic Acid (Glutamate)FDA Link
01/2011
1Retinaldehyde (Retinal)IBA
01/2011
1Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA
09/2010

Therapy/Procedure

1Intravenous Injections
11/2014